Authority: IC 25-22.5-2-7

Affected: IC 25-22.5

Sec. 4. (a) This section establishes protocols for the provision of annual screening or diagnostic testing for a woman who is at least forty (40) years of age and who has been determined to have high breast density.

(b) Follow-up care or testing may include, but is not limited to, the following:

1. (1) Completion of a breast cancer risk assessment using a cancer risk assessment program or performed by a physician with experience in breast cancer risk model selection and interpretation.
2. (2) Educating the patient about the risks, benefits, and costs of additional screening options using magnetic resonance imaging (MRI), ultrasound, tomosynthesis, or other screening modalities.

3. (3) Any recommendations on follow-up care or testing for women over forty (40) years of age with high breast density recommended by:

   1. (A) the American College of Radiology;
   2. (B) the American Cancer Society;
   3. (C) the American Medical Association;
   4. (D) the American Society of Clinical Oncology;
   5. (E) the United States Preventative Services Taskforce;
   6. (F) the Society of Breast Imaging; or
   7. (G) a like professional medical society.
4. (4) Any other actions that are clinically indicated as determined by the physician using the physician's professional judgment.

(c) Nothing in this section should be construed to replace routine mammogram screenings.

(d) Nothing in this section should be construed to mandate a particular course of follow-up care or testing.

(e) A physician shall not be required to proceed with any course of follow-up care or testing that may be harmful or not beneficial to the patient in the physician's professional judgment.

(Medical Licensing Board of Indiana; 844 IAC 16-1-4; filed Sep 23, 2016, 9:04 a.m.: 20161019-IR-844150299FRA; readopted filed Nov 22, 2022, 12:22 p.m.: 20221221-IR- 844220255RFA; readopted filed Feb 27, 2024, 10:19 a.m.: 20240327-IR-844230772RFA)